Ocular Therapeutix, Inc. (NASDAQ:OCUL)

CAPS Rating: 2 out of 5

Caps

How do you think OCUL will perform against the market?

Add Stock to CAPS Watchlist

All Players

15 Outperform
2 Underperform
 

All-Star Players

2 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top OCUL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Top Bull Pitch

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches below!

TSIF (99.97)
Submitted February 17, 2016

Approval to do a Phase III is good news. First of TWO to start in two quarters and last....Meaning a long way to validate anything.I'm not a fan of a "sustained release" anything, but even if I were, based on their track record, however, despite the… More

OCUL VS S&P 500 (SPY)

OCUL Summary

Recent Community Commentary

Read the most recent pitches from players about OCUL.

Recs

0
Member Avatar NoPlaceLikeHome (49.46) Submitted: 5/9/2017 4:15:50 PM : Outperform Start Price: $8.11 OCUL Score: -46.43

This stock is under $250M market cap and has an approved drug ready to serve a several billion dollar market as soon as it fixes some manufacturing items. The risk/reward is too good to pass up.

Recs

0
Member Avatar ACave1 (< 20) Submitted: 4/6/2017 5:28:57 PM : Outperform Start Price: $8.12 OCUL Score: -48.45

FDA approval expected in July for Dextenza eye insert for post-cataracts surgery to reduce swelling and pain. Recent clinical trial yielding very positive results. At an attractive price, Cowen and Company gave this a $60+ price target. FDA approval will give this stock a huge boost.

Leaderboard

Find the members with the highest scoring picks in OCUL.

Score Leader

HDTVBG

HDTVBG (< 20) Score: +283.16

The Score Leader is the player with the highest score across all their picks in OCUL.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
Ajormond 58.83 9/1/2017 Underperform 3Y $6.30 -21.11% +4.01% +25.12 0 Comment
marsuculix 35.63 7/12/2017 Underperform 3M $5.50 -9.64% +5.98% +15.62 0 Comment
Under5 < 20 11/14/2017 Outperform 5Y $5.27 -5.69% +0.12% -5.81 0 Comment
HDTVBG < 20 11/13/2017 Outperform 3W $5.35 -7.10% +0.21% -7.32 0 Comment
HoyBoy < 20 8/5/2016 Outperform 5Y $5.89 -15.62% +18.71% -34.33 0 Comment
tenmiles 40.26 7/7/2017 Outperform 5Y $7.21 -31.07% +6.53% -37.60 0 Comment
geneticbiscuit 88.56 1/24/2017 Outperform 3M $6.74 -26.26% +13.77% -40.03 0 Comment
NoPlaceLikeHome 49.46 5/10/2017 Outperform 3Y $8.11 -38.72% +7.72% -46.43 1 Comment
jeepdrew222 71.87 10/3/2016 Outperform 5Y $6.86 -27.55% +19.48% -47.03 0 Comment
ACave1 < 20 4/7/2017 Outperform 3M $8.12 -38.79% +9.66% -48.45 1 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for OCUL.

Featured Broker Partners